Close Menu

Takara Bio

The method was developed in the laboratory of Rickard Sandberg at the Ludwig Institute for Cancer Research in Stockholm and published by his group in 2013.

The firm said that product revenues in Q4 2014 were up more than fourfold year over year, while license and royalty revenues were flat. 

The collaboration will use Wafergen's sample preparation technology for the potential development of an affordable and large-scale screening test for BRCA1/2.

A proof-of-concept study with BGI has given WaferGen confidence to make SmartChip for single-cell genomics the firm's flagship product. 

The firm's president and CEO said there are no imminent financing plans.

NEW YORK (GenomeWeb) ― Tracking immunity and virus shedding after oral polio vaccination usually requires culture of poliovirus from stool samples.

NEW YORK (GenomeWeb) — WaferGen Biosystems reported today that its third quarter revenues jumped 221 percent year over year primarily due to sales of its recently acquired sequencing library preparation products.

NEW YORK (GenomeWeb News) — Genedata announced today that Takara Bio has chosen the Genedata Expressionist software platform for use in all its genomics, transcriptomics, and epigenomics research.

NEW YORK (GenomeWeb) – Clontech Laboratories today announced a non-exclusive licensing deal with the Broad Institute for its CRISPR-Cas9 technology.

NEW YORK (GenomeWeb) – WaferGen Biosystems announced today that it has completed an offering of common stock and warrants that brought in gross proceeds of $20 million.

Pages

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.